FDA And EMA Evaluate Claims As Nitrosamine Worries Turn To Zantac

 
• By Bowman Cox
collage of the periodic table and test tubes, pipette
Will regulators confirm that ranitidine risks were missed for decades?

More from Manufacturing

More from Compliance